CENTAUR MEDIA PLC Logo

CENTAUR MEDIA PLC

Provides business intelligence, learning, and consultancy for marketing & legal professionals.

CAU | IL

Overview

Corporate Details

ISIN(s):
GB0034291418
LEI:
2138005WK87G7DQRQI62
Country:
United Kingdom
Address:
10 YORK ROAD, SE1 7ND LONDON
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Centaur Media PLC is an international provider of business intelligence, learning, and specialist consultancy services. The company focuses on the marketing and legal industries, operating through a portfolio of leading brands. Its two primary segments are Xeim, which serves the marketing and communications sector, and The Lawyer, a key resource for the legal profession. Centaur delivers strategically important services and develops proprietary datasets, aiming to provide its customers with essential information and a competitive advantage, enabling professionals and businesses to excel.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-08 15:00
Regulatory News Service
Sale of The Lawyer
English 11.0 KB
2025-09-17 08:00
Interim Report
Interim results for the 6 months ended 30 Jun 2025
English 867.2 KB
2025-09-05 15:00
Major Shareholding Notification
Holding(s) in Company
English 53.2 KB
2025-08-27 13:30
Major Shareholding Notification
Holding(s) in Company
English 53.1 KB
2025-08-19 10:39
Major Shareholding Notification
Holding(s) in Company
English 52.8 KB
2025-07-18 12:30
M&A Activity
Sale of MiniMBA and Notice of Results
English 12.0 KB
2025-06-25 08:00
M&A Activity
Conditional agreement for the sale of MiniMBA
English 82.0 KB
2025-05-09 09:16
M&A Activity
Response to Media Speculation
English 7.6 KB
2025-05-08 16:23
Post-Annual General Meeting Information
Signed Resolutions from Annual General Meeting
English 2.4 MB
2025-04-03 16:11
Remuneration Information
Revised Centaur Media LTIP Rules
English 487.8 KB
2025-04-03 16:08
Proxy Solicitation & Information Statement
Proxy Form 2025
English 100.5 KB
2025-04-03 16:06
Pre-Annual General Meeting Information
Notice of AGM 2025
English 98.1 KB
2025-03-19 08:00
Earnings Release
Preliminary results for the year ended 31 Dec 2024
English 1.1 MB
2025-02-24 08:00
Director's Dealing
Director/PDMR Shareholding
English 17.0 KB
2025-02-05 08:00
Board/Management Information
Director Declaration
English 7.2 KB

Automate Your Workflow. Get a real-time feed of all CENTAUR MEDIA PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for CENTAUR MEDIA PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Developing novel cancer immunotherapies, including peptide vaccines and iPS-NKT cell therapies.
Japan 4594
Brilliant Future AB Logo
A data-driven survey platform to measure and improve employee & customer experiences.
Sweden BRILL
b-style holdings,Inc. Logo
Offers flexible staffing for homemakers and specialized recruitment for skilled professionals.
Japan 302A
BTS Group Logo
Helps organizations execute strategy via experiential learning for leadership and sales teams.
Sweden BTS
B.U Technology Logo
Commercializes university research via IP management, licensing, and new venture creation.
South Korea 230980
Advancing high-grade copper and precious metal projects from discovery to production.
Canada N/A
Cantargia Logo
Develops antibody treatments targeting IL1RAP for cancer and autoimmune/inflammatory diseases.
Sweden CANTA
Captor Therapeutics S.A. Logo
Developing TPD therapeutics for oncology and autoimmune diseases with its Optigrade™ platform.
Poland CTX
Offers one-stop BPO, CRM, and staffing for admin, manufacturing, and logistics.
Japan 6070
Carna Biosciences, Inc. Logo
Develops kinase inhibitor drugs for oncology/autoimmune diseases & offers discovery support services.
Japan 4572

Talk to a Data Expert

Have a question? We'll get back to you promptly.